2002 Labelling Pharmaceutical Companies 
Eye on FDA
AUGUST 2, 2022
There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.
The Thyroid Pharmacist
JULY 7, 2023
I really wish that this supplement would come back, and it’s one of the drug entities I would like to create if I ever win the lottery and start my own pharmaceutical company. Published in 2002. Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers Surg Med. 2010;42(6):589-596. doi:10.1002/lsm.20941
Expert insights. Personalized for you.
88 
Let's personalize your content